- call +1-201-465-4211
- email sales@mrinsights.biz
Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoarthritis, are among others.
Scope of the Report:
This report focuses on the Arthritis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Growing burden of incidence of osteoarthritis, psoriatic arthritis and rheumatoid arthritis patients are major factors driving the growth of global arthritis drugs market. According to CDC estimation from 2010-2012, about 52.5 million US adults had some form of arthritis conditions among them persons with age 65 or older reported higher prevalence of arthritis conditions than the other ages due to “wear and tear” on the joints. However, due to lack of proper medication to cure arthritis and higher cost of the medications are hindering the growth of this market over the forecast period.
The worldwide market for Arthritis Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Novartis
Eli Lilly
Celltrion
F. Hoffmann-La Roche
Pfizer
Johnson & Johnson
GSK
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Synthetic DMARDs
Biological DMARDs
NSAIDs
Corticosteroids
Analgesics
Market Segment by Applications, can be divided into
Retail Pharmacies
Hospital Pharmacies
Drug Stores
E-Commerce
There are 15 Chapters to deeply display the global Arthritis Drug market.
Chapter 1, to describe Arthritis Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Arthritis Drug, with sales, revenue, and price of Arthritis Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Arthritis Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Arthritis Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Arthritis Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Arthritis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Synthetic DMARDs
1.2.2 Biological DMARDs
1.2.3 NSAIDs
1.2.4 Corticosteroids
1.2.5 Analgesics
1.3 Market Analysis by Applications
1.3.1 Retail Pharmacies
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Arthritis Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Arthritis Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celltrion
2.3.1 Business Overview
2.3.2 Arthritis Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Celltrion Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 F. Hoffmann-La Roche
2.4.1 Business Overview
2.4.2 Arthritis Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 F. Hoffmann-La Roche Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Arthritis Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Arthritis Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 GSK
2.7.1 Business Overview
2.7.2 Arthritis Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GSK Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Arthritis Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Arthritis Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Arthritis Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Arthritis Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Arthritis Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Arthritis Drug Market Analysis by Regions
4.1 Global Arthritis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Arthritis Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Arthritis Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Arthritis Drug Sales and Growth Rate (2013-2018)
4.3 Europe Arthritis Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Arthritis Drug Sales and Growth Rate (2013-2018)
4.5 South America Arthritis Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Arthritis Drug Sales and Growth Rate (2013-2018)
5 North America Arthritis Drug by Countries
5.1 North America Arthritis Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Arthritis Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Arthritis Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Arthritis Drug Sales and Growth Rate (2013-2018)
5.3 Canada Arthritis Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Arthritis Drug Sales and Growth Rate (2013-2018)
6 Europe Arthritis Drug by Countries
6.1 Europe Arthritis Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Arthritis Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Arthritis Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Arthritis Drug Sales and Growth Rate (2013-2018)
6.3 UK Arthritis Drug Sales and Growth Rate (2013-2018)
6.4 France Arthritis Drug Sales and Growth Rate (2013-2018)
6.5 Russia Arthritis Drug Sales and Growth Rate (2013-2018)
6.6 Italy Arthritis Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Arthritis Drug by Countries
7.1 Asia-Pacific Arthritis Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Arthritis Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Arthritis Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Arthritis Drug Sales and Growth Rate (2013-2018)
7.3 Japan Arthritis Drug Sales and Growth Rate (2013-2018)
7.4 Korea Arthritis Drug Sales and Growth Rate (2013-2018)
7.5 India Arthritis Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Arthritis Drug Sales and Growth Rate (2013-2018)
8 South America Arthritis Drug by Countries
8.1 South America Arthritis Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Arthritis Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Arthritis Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Arthritis Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Arthritis Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Arthritis Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Arthritis Drug by Countries
9.1 Middle East and Africa Arthritis Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Arthritis Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Arthritis Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Arthritis Drug Sales and Growth Rate (2013-2018)
9.3 UAE Arthritis Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Arthritis Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Arthritis Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Arthritis Drug Sales and Growth Rate (2013-2018)
10 Global Arthritis Drug Market Segment by Type
10.1 Global Arthritis Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Arthritis Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Arthritis Drug Revenue and Market Share by Type (2013-2018)
10.2 Synthetic DMARDs Sales Growth and Price
10.2.1 Global Synthetic DMARDs Sales Growth (2013-2018)
10.2.2 Global Synthetic DMARDs Price (2013-2018)
10.3 Biological DMARDs Sales Growth and Price
10.3.1 Global Biological DMARDs Sales Growth (2013-2018)
10.3.2 Global Biological DMARDs Price (2013-2018)
10.4 NSAIDs Sales Growth and Price
10.4.1 Global NSAIDs Sales Growth (2013-2018)
10.4.2 Global NSAIDs Price (2013-2018)
10.5 Corticosteroids Sales Growth and Price
10.5.1 Global Corticosteroids Sales Growth (2013-2018)
10.5.2 Global Corticosteroids Price (2013-2018)
10.6 Analgesics Sales Growth and Price
10.6.1 Global Analgesics Sales Growth (2013-2018)
10.6.2 Global Analgesics Price (2013-2018)
11 Global Arthritis Drug Market Segment by Application
11.1 Global Arthritis Drug Sales Market Share by Application (2013-2018)
11.2 Retail Pharmacies Sales Growth (2013-2018)
11.3 Hospital Pharmacies Sales Growth (2013-2018)
11.4 Drug Stores Sales Growth (2013-2018)
11.5 E-Commerce Sales Growth (2013-2018)
12 Arthritis Drug Market Forecast (2018-2023)
12.1 Global Arthritis Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Arthritis Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Arthritis Drug Market Forecast (2018-2023)
12.2.2 Europe Arthritis Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Arthritis Drug Market Forecast (2018-2023)
12.2.4 South America Arthritis Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Arthritis Drug Market Forecast (2018-2023)
12.3 Arthritis Drug Market Forecast by Type (2018-2023)
12.3.1 Global Arthritis Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Arthritis Drug Market Share Forecast by Type (2018-2023)
12.4 Arthritis Drug Market Forecast by Application (2018-2023)
12.4.1 Global Arthritis Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Arthritis Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Arthritis Drug Picture
Table Product Specifications of Arthritis Drug
Figure Global Sales Market Share of Arthritis Drug by Types in 2017
Table Arthriti
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
